Free Trial

CeriBell (CBLL) Competitors

CeriBell logo
$11.91 +0.21 (+1.79%)
Closing price 04:00 PM Eastern
Extended Trading
$11.93 +0.02 (+0.17%)
As of 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CBLL vs. EYE, LMAT, CNMD, LQDA, ENOV, AORT, CDRE, NVCR, SSII, and ESTA

Should you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include National Vision (EYE), LeMaitre Vascular (LMAT), CONMED (CNMD), Liquidia Technologies (LQDA), Enovis (ENOV), Artivion (AORT), Cadre (CDRE), NovoCure (NVCR), SS Innovations International (SSII), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

CeriBell vs. Its Competitors

CeriBell (NASDAQ:CBLL) and National Vision (NASDAQ:EYE) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

National Vision has a net margin of -0.75% compared to CeriBell's net margin of -63.83%. National Vision's return on equity of 3.56% beat CeriBell's return on equity.

Company Net Margins Return on Equity Return on Assets
CeriBell-63.83% -48.42% -28.50%
National Vision -0.75%3.56%1.49%

CeriBell currently has a consensus target price of $32.14, suggesting a potential upside of 169.88%. National Vision has a consensus target price of $24.73, suggesting a potential upside of 6.49%. Given CeriBell's stronger consensus rating and higher probable upside, equities research analysts plainly believe CeriBell is more favorable than National Vision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CeriBell
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00
National Vision
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, National Vision had 8 more articles in the media than CeriBell. MarketBeat recorded 16 mentions for National Vision and 8 mentions for CeriBell. National Vision's average media sentiment score of 1.01 beat CeriBell's score of 0.41 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CeriBell
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
National Vision
3 Very Positive mention(s)
8 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision has higher revenue and earnings than CeriBell. National Vision is trading at a lower price-to-earnings ratio than CeriBell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CeriBell$65.44M6.67-$40.46M-$2.99-3.98
National Vision$1.89B0.98-$28.50M-$0.18-129.00

Summary

National Vision beats CeriBell on 8 of the 13 factors compared between the two stocks.

Get CeriBell News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CBLL vs. The Competition

MetricCeriBellMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$436.62M$10.53B$5.64B$9.81B
Dividend YieldN/A2.00%4.64%4.14%
P/E Ratio-3.9820.0630.1125.78
Price / Sales6.6724.89430.17159.31
Price / CashN/A23.7337.7258.50
Price / Book2.533.118.476.07
Net Income-$40.46M$209.94M$3.26B$265.11M
7 Day Performance-6.81%8.82%3.56%2.90%
1 Month Performance-26.16%9.93%5.97%3.99%
1 Year PerformanceN/A-6.89%42.70%26.92%

CeriBell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CBLL
CeriBell
2.4414 of 5 stars
$11.91
+1.8%
$32.14
+169.9%
N/A$436.62M$65.44M-3.98N/A
EYE
National Vision
3.0343 of 5 stars
$25.07
+3.6%
$24.18
-3.5%
+123.2%$1.91B$1.82B-75.9713,411Positive News
Earnings Report
LMAT
LeMaitre Vascular
2.1926 of 5 stars
$84.36
+4.1%
$97.83
+16.0%
+15.0%$1.83B$226.26M42.61490Insider Trade
CNMD
CONMED
3.958 of 5 stars
$53.46
+2.2%
$59.80
+11.9%
-18.1%$1.62B$1.31B15.153,900Dividend Announcement
LQDA
Liquidia Technologies
3.0063 of 5 stars
$19.48
+10.2%
$26.89
+38.0%
+97.4%$1.51B$14M-12.3350Trending News
Earnings Report
Analyst Forecast
Options Volume
Gap Up
ENOV
Enovis
3.8899 of 5 stars
$26.61
+3.4%
$55.60
+109.0%
-32.2%$1.47B$2.11B-1.917,367News Coverage
Earnings Report
Analyst Revision
AORT
Artivion
2.9621 of 5 stars
$32.06
+3.7%
$32.40
+1.1%
+73.9%$1.32B$388.54M-64.121,600Earnings Report
Analyst Downgrade
CDRE
Cadre
1.8352 of 5 stars
$33.09
+2.3%
$37.50
+13.3%
-12.7%$1.31B$567.56M34.832,284News Coverage
Analyst Downgrade
Analyst Revision
NVCR
NovoCure
4.4878 of 5 stars
$11.76
+3.9%
$28.79
+144.8%
-38.3%$1.27B$605.22M-7.541,488
SSII
SS Innovations International
N/A$6.57
+6.0%
N/AN/A$1.20B$20.65M0.004Gap Up
ESTA
Establishment Labs
2.1204 of 5 stars
$42.72
+3.3%
$54.83
+28.4%
-18.1%$1.20B$166.02M-13.781,018Earnings Report

Related Companies and Tools


This page (NASDAQ:CBLL) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners